Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Ablation Strategies for Persistent Atrial Fibrillation With Heart Failure - Optimization of Intervention Strategies for Persistent Atrial Fibrillation

NCT07153718 is registered in ClinicalTrials.gov with Xu Liu as lead sponsor.

NCT NCT07153718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07153718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Ablation Strategies for Persistent Atrial Fibrillation With Heart Failure - Optimization of Intervention Strategies for Persistent Atrial Fibrillation
Lead sponsor
Xu Liu
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2021
Completion date
December 31, 2026
Enrollment
300 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, persistent atrial fibrillation